Federal regulators are pressing the Supreme Court to stop big pharmaceuticals from paying generic drug competitors to delay releasing cheaper versions of brand-name drugs.
The Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off the market.
Discussing health care in China, the promotion of female executives, and the state of his business, with Cardinal Health CEO George Barrett. "Health care in China has been a tremendous opportunity for our company," he says.
Walgreen and partner Alliance Boots will take up to a 23 percent stake in AmerisourceBergen, ending Walgreen's current contract with Cardinal Health.
Like all computers, Intuitive Surgical's da Vinci robot can malfunction during surgery. A range of results have been reported by surgeons.
In recent years, as the surgical robot's popularity has grown, so have questions and concerns about its safety, training and the aggressiveness of its marketing.
Congress wants a second look at how private firms profit from public research after Pfizer and the National Institutes of Health developed a potentially lucrative new drug. The NYT reports.
Obamacare and the aging of doctors and patients are exacerbating the shortage of primary care physicians.
Spending on drugs to treat common diseases fell 1.5 percent among customers who receive prescription benefits through commercial insurers.
Moves by Indonesia's President Susilo Bambang Yudhoyono to put his finance minister in charge of the central bank is leading to concerns that he may be seeking someone more malleable to run the state coffers in the run up to next year's elections.
A baby girl in Mississippi who was born with HIV has been cured after very early treatment with standard HIV drugs, U.S. researchers reported on Sunday.
If you smoke, you might have to pay thousands extra for employee-based health insurance under Obamacare starting next year.
The Obama administration has outlined the essential health benefits that insurers must offer to consumers in individual and small group markets under Obamacare.
Dr Amit Roy, managing director and head of healthcare research at Nomura, tells CNBC that the ability to keep making new blockbuster drugs depends on the medicine.
Humana said the government's proposed 2014 payment rates for Medicare participants were lower than expected and would affect its profit outlook, and its shares fell in premarket trading.
Novartis said it would scrap a 72 million Swiss franc ($77.98 million) pay package for outgoing chairman Daniel Vasella, bowing to mounting anger in Switzerland before an investor meeting on Friday.
Melissa Boudreault, CGI vp of state health solutions, talks to CNBC's Bertha Coombs about the Federally-built health care exchange. She believes it will be a tremendous resource to consumers, because it must meet the needs of a number of different states.
Shares of Ziopharm Oncology gapped higher this week, and traders are betting on even larger gains ahead.
Drugmaker Merck said Wednesday that the devaluation of Venezuela's currency will reduce its net income by about $200 million this year.
U.S. regulators dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by demanding the Danish drugmaker conduct additional clinical tests to assess potential heart risks.